ILMN Illumina Inc
- Stocks
- Healthcare
- NASDAQ: ILMN
Price (delayed)
$121.62
Market cap
$18.58B
P/E Ratio
27.21
Dividend/share
N/A
EPS
$4.47
Enterprise value
$20.03B
Relative Growth:
Rel. Growth:
32
Relative Strength:
Rel. Strength:
70
Relative Valuation:
Rel. Valuation:
66
Relative Profitability:
Rel. Profitability:
97
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
Highlights
The equity has increased by 12% YoY and by 5% from the previous quarter
Illumina's debt has decreased by 4% YoY
Illumina's EPS has surged by 145% YoY but it has decreased by 44% QoQ
ILMN's net income has soared by 144% year-on-year but it is down by 44% since the previous quarter
The quick ratio has contracted by 39% YoY and by 20% from the previous quarter
Illumina's revenue has decreased by 2.3% YoY
Key stats
What are the main financial stats of ILMN
Market
Valuations
Earnings
Shares outstanding
152.8M
Market cap
$18.58B
Enterprise value
$20.03B
Price to earnings (P/E)
27.21
Price to book (P/B)
7.85
Price to sales (P/S)
4.34
PEG
0.19
EV/EBIT
20.13
EV/EBITDA
15.77
EV/Sales
4.67
Revenue
$4.29B
Gross profit
$2.84B
Operating income
$780M
Net income
$703M
EBIT
$995M
EBITDA
$1.27B
Free cash flow
$1B
Per share
Balance sheet
Liquidity
EPS
$4.47
EPS diluted
$4.46
Free cash flow per share
$6.54
Book value per share
$15.49
Revenue per share
$28.03
TBVPS
$31.63
Total assets
$6.18B
Total liabilities
$3.8B
Debt
$2.5B
Equity
$2.38B
Working capital
$834M
Debt to equity
1.05
Current ratio
1.43
Quick ratio
1.02
Net debt/EBITDA
1.14
Margins
Efficiency
Dividend
EBITDA margin
29.6%
Gross margin
66.2%
Net margin
16.4%
Operating margin
18.2%
Return on assets
11.4%
Return on equity
30%
Return on invested capital
21.3%
Return on capital employed
23.6%
Return on sales
23.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ILMN stock price
How has the Illumina stock price performed over time
Intraday
-0.67%
1 week
22.84%
1 month
20.39%
1 year
-19.9%
YTD
-8.99%
QTD
28.06%
Financial performance
How have Illumina's revenue and profit performed over time
Revenue
$4.29B
Gross profit
$2.84B
Operating income
$780M
Net income
$703M
Gross margin
66.2%
Net margin
16.4%
Illumina's operating margin has soared by 168% YoY but it has decreased by 40% from the previous quarter
The operating income has soared by 167% YoY but it has decreased by 40% from the previous quarter
Illumina's net margin has surged by 145% YoY but it has decreased by 44% QoQ
ILMN's net income has soared by 144% year-on-year but it is down by 44% since the previous quarter
Price vs fundamentals
How does ILMN's price correlate with its fundamentals
Growth
What is Illumina's growth rate over time
Valuation
What is Illumina stock price valuation
P/E
27.21
P/B
7.85
P/S
4.34
EV/EBIT
20.13
EV/EBITDA
15.77
EV/Sales
4.67
Illumina's EPS has surged by 145% YoY but it has decreased by 44% QoQ
The price to book (P/B) is 18% higher than the 5-year quarterly average of 6.7 and 18% higher than the last 4 quarters average of 6.7
The equity has increased by 12% YoY and by 5% from the previous quarter
ILMN's P/S is 46% below its 5-year quarterly average of 8.1 but 21% above its last 4 quarters average of 3.6
Illumina's revenue has decreased by 2.3% YoY
Efficiency
How efficient is Illumina business performance
Illumina's return on sales has surged by 171% YoY but it has decreased by 34% QoQ
The ROE has soared by 171% YoY but it has contracted by 46% from the previous quarter
ILMN's return on invested capital has surged by 167% year-on-year but it is down by 30% since the previous quarter
The company's return on assets has surged by 158% YoY but it fell by 44% QoQ
Dividends
What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ILMN.
Financial health
How did Illumina financials performed over time
The total assets is 63% more than the total liabilities
The current ratio has contracted by 41% YoY and by 21% from the previous quarter
The quick ratio has contracted by 39% YoY and by 20% from the previous quarter
Illumina's debt is 4.9% higher than its equity
The debt to equity is down by 14% year-on-year and by 6% since the previous quarter
The equity has increased by 12% YoY and by 5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.